Regulation of telomerase activity by apparently opposing elements

被引:44
作者
Liu, Jun-Ping [1 ]
Chen, Shi-Ming [2 ,3 ]
Cong, Yu-Sheng [4 ]
Nicholls, Craig [1 ]
Zhou, Shu-Feng [5 ]
Tao, Ze-Zhang [2 ,3 ]
Li, He [1 ]
机构
[1] Monash Univ, Mol Signaling Lab, Dept Immunol, Cent Clin Sch,AMREP, Melbourne, Vic 3004, Australia
[2] Wuhan Univ, Otolaryngol Head Neck Inst, Wuhan 430060, Hubei, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
[4] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Beijing 100875, Peoples R China
[5] RMIT Univ, Sch Hlth Sci, Bundoora, Vic 3083, Australia
基金
中国国家自然科学基金; 英国医学研究理事会;
关键词
Telomerase; Gene expression; Regulation; Cancer; ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN-7; REVERSE-TRANSCRIPTASE HTERT; CD8(+) T-CELLS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2)-INDUCED APOPTOSIS; SYNERGISTIC DOWN-REGULATION; TYROSINE KINASE INHIBITOR; ESTROGEN-RECEPTOR-ALPHA;
D O I
10.1016/j.arr.2010.03.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Telomeres, the ends of chromosomes, undergo frequent remodeling events that are important in cell development, proliferation and differentiation, and neoplastic immortalization. It is not known how the cellular environment influences telomere remodeling, stability, and lengthening or shortening. Telomerase is a ribonucleoprotein complex that maintains and lengthens telomeres in the majority of cancers. Recent studies indicate that a number of factors, including hormones, cytokines, ligands of nuclear receptor, vitamins and herbal extracts have significantly influence telomerase activity and, in some instances, the remodeling of telomeres. This review summarizes the advances in understanding of the positive and negative regulation by extracellular factors of telomerase activity in cancer, stem cells and other systems in mammals. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:245 / 256
页数:12
相关论文
共 176 条
[51]   Telomerase and cancer therapeutics [J].
Harley, Calvin B. .
NATURE REVIEWS CANCER, 2008, 8 (03) :167-179
[52]   Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells [J].
Herbert, BS ;
Wright, AC ;
Passons, CM ;
Wright, WE ;
Ali, IU ;
Kopelovich, L ;
Shay, JW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (01) :39-45
[53]   Bone morphogenetic proteins: Multifunctional regulators of vertebrate development [J].
Hogan, BLM .
GENES & DEVELOPMENT, 1996, 10 (13) :1580-1594
[54]   Regulation of Telomerase Activity by Interferon Regulatory Factors 4 and 8 in Immune Cells [J].
Hrdlickova, Radmila ;
Nehyba, Jiri ;
Bose, Henry R., Jr. .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (03) :929-941
[55]   Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter -: effect on telomerase expression and telomere length maintenance in non-small cell lung cancer [J].
Hsu, Chung-Ping ;
Hsu, Nan-Yuan ;
Lee, Li-Wen ;
Ko, Jiunn-Liang .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (10) :1466-1474
[56]   Role of Smad3 in the regulation of rat telomerase reverse transcriptase byTGFβ [J].
Hu, B ;
Tack, DC ;
Liu, T ;
Wu, Z ;
Ullenbruch, MR ;
Phan, SH .
ONCOGENE, 2006, 25 (07) :1030-1041
[57]   Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia [J].
Hu, Jiong ;
Liu, Yuan-Fang ;
Wu, Chuan-Feng ;
Xu, Fang ;
Shen, Zhi-Xiang ;
Zhu, Yong-Mei ;
Li, Jun-Min ;
Tang, Wei ;
Zhao, Wei-Li ;
Wu, Wen ;
Sun, Hui-Ping ;
Chen, Qiu-Sheng ;
Chen, Bing ;
Zhou, Guang-Biao ;
Zelent, Arthur ;
Waxman, Samuel ;
Wang, Zhen-Yi ;
Chen, Sai-Juan ;
Chen, Zhu .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) :3342-3347
[58]   Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT [J].
Iczkowski, KA ;
Huang, W ;
Mazzucchelli, R ;
Pantazis, CG ;
Stevens, GR ;
Montironi, R .
CANCER, 2004, 100 (02) :294-299
[59]   Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor [J].
Igarashi, H ;
Sakaguchi, N .
BLOOD, 1997, 89 (04) :1299-1307
[60]  
Ikeda N, 2003, MOL CANCER THER, V2, P739